Trial Profile
Imaging patterns and clinical use of PET and CT after first-line rituximab (R)-based induction therapy in clinical practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jan 2018
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 11 Jan 2018 New trial record